Aimee DiMarco1,2, Ravi Chotalia1, Ruth Bloxham1, Charlotte McIntyre1,2, Neil Tolley1,2, F Fausto Palazzo3,4. 1. Department of Endocrine Surgery, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK. 2. Department of Surgery and Cancer, Imperial College London, London, UK. 3. Department of Endocrine Surgery, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK. f.palazzo@imperial.ac.uk. 4. Department of Surgery and Cancer, Imperial College London, London, UK. f.palazzo@imperial.ac.uk.
Abstract
BACKGROUND: The inability to identify the pathological gland at surgery results in failure to cure hyperparathyroidism in 2-5%. The poorly understood characteristic of parathyroid tissue to manifest autofluorescence (AF) under near-infrared (NIR) light has been promoted as an intraoperative adjunct in parathyroid surgery. This study sought to explore potential clinical correlates for AF and assess the clinical utility of AF in parathyroid surgery. METHODS: Consecutive patients undergoing parathyroid surgery for primary and renal disease were included. NIR imaging was used intraoperatively and the degree of AF of parathyroid glands graded by the operating surgeon. Variables assessed for correlation with AF were: pre-operative serum calcium and PTH, SestaMIBI positivity, gland weight and histological composition. RESULTS: Ninety-six patients underwent parathyroidectomy over an 8-month period: 49 bilateral explorations, 41 unilateral and 6 focussed lateral approaches: 284 potentially 'visualisable' glands in total. Two hundred and fifty-seven glands (90.5%) were visualised with NIR. Correlation was found between the degree of fluorescence and pre-operative serum calcium and PTH, but not between gland weight and SestaMIBI positivity. In those with renal hyperparathyroidism, a predominance of oxyphil cells correlated with increased AF. CONCLUSION: Autofluorescence intensity correlates with serum calcium, PTH and gland composition. Further refinements would be required for this information to be of value in a clinical setting. Improvements allowing NIR to visualise the additional 9.5% of parathyroids and overcome the variation in signal intensity due to depth of access are required for the routine adoption of this technology. At present, its routine use in a clinical setting cannot be justified.
BACKGROUND: The inability to identify the pathological gland at surgery results in failure to cure hyperparathyroidism in 2-5%. The poorly understood characteristic of parathyroid tissue to manifest autofluorescence (AF) under near-infrared (NIR) light has been promoted as an intraoperative adjunct in parathyroid surgery. This study sought to explore potential clinical correlates for AF and assess the clinical utility of AF in parathyroid surgery. METHODS: Consecutive patients undergoing parathyroid surgery for primary and renal disease were included. NIR imaging was used intraoperatively and the degree of AF of parathyroid glands graded by the operating surgeon. Variables assessed for correlation with AF were: pre-operative serum calcium and PTH, SestaMIBI positivity, gland weight and histological composition. RESULTS: Ninety-six patients underwent parathyroidectomy over an 8-month period: 49 bilateral explorations, 41 unilateral and 6 focussed lateral approaches: 284 potentially 'visualisable' glands in total. Two hundred and fifty-seven glands (90.5%) were visualised with NIR. Correlation was found between the degree of fluorescence and pre-operative serum calcium and PTH, but not between gland weight and SestaMIBI positivity. In those with renal hyperparathyroidism, a predominance of oxyphil cells correlated with increased AF. CONCLUSION: Autofluorescence intensity correlates with serum calcium, PTH and gland composition. Further refinements would be required for this information to be of value in a clinical setting. Improvements allowing NIR to visualise the additional 9.5% of parathyroids and overcome the variation in signal intensity due to depth of access are required for the routine adoption of this technology. At present, its routine use in a clinical setting cannot be justified.
Authors: Melanie A McWade; Constantine Paras; Lisa M White; John E Phay; Carmen C Solórzano; James T Broome; Anita Mahadevan-Jansen Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958
Authors: Matthew D Keller; Shovan K Majumder; Mark C Kelley; Ingrid M Meszoely; Fouad I Boulos; Graciela M Olivares; Anita Mahadevan-Jansen Journal: Lasers Surg Med Date: 2010-01 Impact factor: 4.025
Authors: Melanie A McWade; Constantine Paras; Lisa M White; John E Phay; Anita Mahadevan-Jansen; James T Broome Journal: Surgery Date: 2013-12 Impact factor: 3.982
Authors: Frederic Ris; Roel Hompes; Chris Cunningham; Ian Lindsey; Richard Guy; Oliver Jones; Bruce George; Ronan A Cahill; Neil J Mortensen Journal: Surg Endosc Date: 2014-02-25 Impact factor: 4.584
Authors: Giju Thomas; Carmen C Solórzano; Naira Baregamian; Emmanuel A Mannoh; Rekha Gautam; Rebecca T Irlmeier; Fei Ye; Jon A Nelson; Samuel E Long; Paul G Gauger; Alexa Magner; Tyler Metcalf; Lawrence A Shirley; John E Phay; Anita Mahadevan-Jansen Journal: Am J Surg Date: 2021-05-13 Impact factor: 2.565
Authors: Jonas Wizenty; Teresa Schumann; Donna Theil; Martin Stockmann; Johann Pratschke; Frank Tacke; Felix Aigner; Tilo Wuensch Journal: Molecules Date: 2020-04-30 Impact factor: 4.411
Authors: Andrea L Merrill; Sarah S Sims; Priya H Dedhia; Kara Rossfeld; Abberly Lott Limbach; Quan-Yang Duh; John E Phay Journal: J Endocr Soc Date: 2022-06-06